← Open Payments lookup

ERIK CABRERA: Open Payments

NPI 1003200395 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$160,648 in 204 payments from 6 companies in 2025. Trend: 2023 $76,292 · 2024 $119,736 · 2025 $160,648

Speaker / faculty: $110,512Consulting: $24,700Travel & lodging: $20,919Food & beverage: $4,518
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.161$132,690
Otsuka America Pharmaceutical, Inc.23$18,551
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$9,059
Teva Pharmaceuticals USA, Inc.4$136
Alpha Cognition USA, Inc.1$125
ACADIA Pharmaceuticals Inc1$87

Products named: INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, Zunveyl, NUPLAZID.

Industry payments across FL — which companies pay providers there.